Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia
dc.contributor.author | Lipshitz, Melanie | |
dc.contributor.author | Visser, J. | |
dc.contributor.author | Anderson, Ronald | |
dc.contributor.author | Nel, D.G. | |
dc.contributor.author | Smit, T.G. (Theunis) | |
dc.contributor.author | Steel, Helen Carolyn | |
dc.contributor.author | Rapoport, Bernardo Leon | |
dc.date.accessioned | 2024-05-28T06:51:15Z | |
dc.date.available | 2024-05-28T06:51:15Z | |
dc.date.issued | 2024-05 | |
dc.description | DATA AVAILABILITY : The data that support the findings of this study and related study tools are available from the corresponding author, Melanie Lipshitz (melanielevydietcian@gmail.com), upon reasonable request. | en_US |
dc.description | SUPPLEMENTARY MATERIAL : FIGURE S1. Functional assessment of anorexia / cachexia therapy (FAACTA/CS-12) categories. FIGURE S2. Cachexia categories for cases and controls. TABLE S1. European organisation for the research and treatment of cancer quality of life–C30 questionnaire (EORTC QLQ-C30) scores. | en_US |
dc.description.abstract | PURPOSE : Quality of life (QoL), appetite, cachexia, and biomarkers [albumin, hemoglobin (Hb), neutrophils, lymphocytes, platelets, C-reactive protein (CRP), tumor necrosis factor alpha (TNFα), interleukin 6 (IL-6), interleukin 8 (IL-8), C-X-C motif chemokine ligand 5 (CXCL5) and citrullinated histoneH3 (H3Cit)] were compared for 40 cases with advanced cancer and 40 healthy controls. Baseline differences and significant relationships were explored for biomarkers with QoL, appetite, and cachexia. METHODS : In a prospective case–control, age and sex matched study, the European Organisation for the Research and Treatment of Cancer Quality of Life–C30 questionnaire (EORTC-QLQ-C30) for QoL, the Functional Assessment of Anorexia and Cachexia Therapy assessment (FAACT A/CS-12) for appetite, and a five-factor cachexia assessment tool for cachexia assessment were performed. Routine hematological measurements and blood chemistry analyses together with ELISA procedures and a Multiplex® bead array platform, were used for biomarker analysis. Descriptive statistics and regression analyses were undertaken. P < 0.05 defined statistical significance. RESULTS : Global health status (QL-G), functional scales (QL-FS), and symptom scales (QL-SS) differed for cases and controls (p < 0.01). In cases, differences were observed for QL-G (p < 0.01), QL-FS (p < 0.01), and QL-SS (p = 0.01) compared to standardized references values. FAACT A/CS-12 scores differed significantly between cases and controls (p < 0.01) and 30% of cases scored “poor” appetites. Cachexia was present in 60% of cases. Albumin, lymphocytes, platelets, Hb, platelet to lymphocyte ratio (PLR), systemic immune-inflammation index (SII), CRP, TNFα, all at p < 0.01, neutrophil to lymphocyte ratio (NLR) (p = 0.02), IL-6 (p < 0.04), and IL-8 (p = 0.02) differed significantly between cases and controls. No difference was found for CXCL5 or H3Cit. Albumin NLR, Hb, PLR, SII, TNFα, IL-8, and CRP showed significant relationships with all aspects of QoL. QL-FS was significantly related to CXCL5 (p = 0.04), significant relationships with FAACT A/CS-12 included: NLR (p = 0.002), Hb (p < 0.001), and PLR (p < 0.01). NLR, PLR, SII, TNFα, IL-6, IL-8, and CRP correlated positively to cachexia and albumin while Hb and lymphocyte count correlated negatively to cachexia. CONCLUSION : CXCL5 and H3Cit were not reliable biomarkers for cancer cachexia, nor significantly related to QoL, appetite or cachexia. Albumin, NLR, Hb, PLR, SII, TNFα, IL-8, and CRP were reliable indicators of QoL, appetite, and cachexia. Future research should include other novel biomarkers namely growth differentiation factor-15 (GDF-15), fibroblast growth factor 21 (FGF-21), fractakline, interferon gamma (IFN-y), IL-16, macrophage colony stimulating factor (M-CSF), and macrophage procoagulant–inducing factor (MPIF). | en_US |
dc.description.department | Immunology | en_US |
dc.description.librarian | hj2024 | en_US |
dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
dc.description.sponsorship | Open access funding provided by Stellenbosch University. Partial financial support was received from the Harry Crossly Foundation. | en_US |
dc.description.uri | https://www.springer.com/journal/520 | en_US |
dc.identifier.citation | Lipshitz, M., Visser, J., Anderson, R. et al. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia. Supportive Care in Cancer 32, 349 (2024). https://doi.org/10.1007/s00520-024-08549-5. | en_US |
dc.identifier.issn | 0941-4355 (print) | |
dc.identifier.issn | 1433-7339 (online) | |
dc.identifier.other | 10.1007/s00520-024-08549-5 | |
dc.identifier.uri | http://hdl.handle.net/2263/96260 | |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.rights | © The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. | en_US |
dc.subject | Quality of life (QoL) | en_US |
dc.subject | Anorexia | en_US |
dc.subject | Appetite | en_US |
dc.subject | Biomarkers | en_US |
dc.subject | Cachexia | en_US |
dc.subject | SDG-03: Good health and well-being | en_US |
dc.title | Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 4 of 4
Loading...
- Name:
- Lipshitz_Relationships_2024.pdf
- Size:
- 816.26 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
Loading...
- Name:
- Lipshitz_RelationshipsFigS1_2024.pdf
- Size:
- 63.56 KB
- Format:
- Adobe Portable Document Format
- Description:
- Figure S1
Loading...
- Name:
- Lipshitz_RelationshipsFigS2_2024.pdf
- Size:
- 69.63 KB
- Format:
- Adobe Portable Document Format
- Description:
- Figure S2
Loading...
- Name:
- Lipshitz_RelationshipsTabS1_2024.pdf
- Size:
- 56.08 KB
- Format:
- Adobe Portable Document Format
- Description:
- Table S1
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: